Attending this event?
Back To Schedule
Tuesday, October 25 • 1:15pm - 1:45pm
TRAILBLAZER-ALZ 3: A Decentralized Trial in Preclinical Alzheimer’s Disease

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

  • Key trial design elements of this decentralized preclinical Alzheimer’s disease study
  • Structure of decentralized clinical assessments in preclinical Alzheimer’s disease
  • Benefits of a decentralized clinical trial and the role that digital innovation can play

avatar for Roy Yaari, MD

Roy Yaari, MD

Executive Director, Medical, Neuroscience, Eli Lilly and Company
Dr. Roy Yaari completed his neurology residency and fellowship in Alzheimer’s and dementia at the University of California, San Diego in 2006. Subsequently, he served as a neurologist and then director of the outpatient Memory Clinic at the Banner Alzheimer’s Institute in Phoenix... Read More →

Tuesday October 25, 2022 1:15pm - 1:45pm EDT